Contributions of null and hypomorphic alleles of Apc in mice produce both developmental and pathophysiological phenotypes. To ascribe the resulting genotype-to-phenotype relationship unambiguously to the Wnt/b-catenin pathway, we challenged the allele combinations by genetically restricting intracellular b-catenin expression in the corresponding compound mutant mice. Subsequent evaluation of the extent of resulting Tcf4-reporter activity in mouse embryo fibroblasts enabled genetic measurement of Wnt/b-catenin signaling in the form of an allelic series of mouse mutants. Different permissive Wnt signaling thresholds appear to be required for the embryonic development of head structures, adult intestinal polyposis, hepatocellular carcinomas, liver zonation, and the development of natural killer cells. Furthermore, we identify a homozygous Apc allele combination with Wnt/b-catenin signaling capacity similar to that in the germline of the Apc min mice, where somatic Apc loss-of-heterozygosity triggers intestinal polyposis, to distinguish whether co-morbidities in Apc min mice arise independently of intestinal tumorigenesis. Together, the present genotypephenotype analysis suggests tissue-specific response levels for the Wnt/b-catenin pathway that regulate both physiological and pathophysiological conditions.
Introduction
The evolutionarily conserved Wnt/b-catenin pathway is a critical regulator of proliferation and differentiation and plays a pivotal role during embryonic development and in the maintenance of tissue homeostasis in the adult. A multitude of studies have documented that impaired or excessive activation of the Wnt/b-catenin pathway result in a large number of pathophysiological conditions, including cancer (for review see [1] ). Tight regulation of Wnt/b-catenin signaling is ensured by compartmentalized expression of the different Wnt ligands and receptor components and this is complemented by multiple layers of negative regulation. In particular, the tumor suppressor protein Apc provides a platform for the formation of a b-catenin destruction complex, and thereby acts as a negative regulator of activated Wnt signaling. Loss of Apc function leads to ligandindependent accumulation of b-catenin and its nuclear translocation, where it binds to Tcf/Lef family transcription factors and induces expression of target genes such as Axin2, Cyclin D1 and cMyc that are involved in proliferation and transformation (for review see [2] ).
During embryonic development, Wnt/b-catenin signaling plays an important role in the anterior-posterior patterning of the primary embryonic axis in vertebrates. Unregulated activity of the Wnt pathway during embryonic development leads to anterior defects. For example in mice, loss of Dkk1, a Wnt antagonist, results in truncation of head structures anterior to the midhindbrain boundary [3] and mice doubly deficient for the Wnt antagonists Sfrp1 and Sfrp2 have a shortened anterior-posterior axis [4] . Ectopic expression of Wnt8C in mice causes axis duplication and severe anterior truncations [5] , while embryos lacking functional b-catenin have impaired anterior-posterior axis formation [6] . Embryos homozygous for the mutant Apc min allele, which results in truncation of the full-length 2843 amino acid protein at residue 850 and in heterozygous mice leads to an intestinal phenotype akin to familial adenomatous polyposis (FAP) in humans, fail to develop past the gastrulation stage due to proximalisation of the epiblast and ectopic activation of several posterior mesendodermal genes [7, 8] . While these observations establish indispensable roles for components of the Wnt pathway in patterning the anterior-posterior axis, recent genetic rescue studies have helped to define signaling threshold requirement(s) for head morphogenesis [9] .
Mutations in components of the destruction complex (APC, AXIN, GSK3b etc) are implicated in tumorigenesis and result in aberrant, ligand-independent activation of the WNT/b-CATENIN pathway. For instance truncating nonsense mutations in APC, loss of heterozygosity (LOH) or promoter hypermethylation are most prominently associated with aberrant WNT signaling that is characteristic of more than 90% of sporadic forms of colorectal cancer in humans [10] [11] [12] . Meanwhile epigenetic and genetic impairment mutations that reduce expression of wild-type AXIN2/ CONDUCTIN [13, 14] or amino-terminal missense mutations in CTNNB1 (b-CATENIN) [15] are most commonly associated with aberrant WNT signaling in cancers of the liver (hepatocellular carcinoma and hepatoblastoma), stomach, kidney (Wilms tumor) and ovaries. It remains unclear why in humans the intestinal epithelium is most sensitive to cancer-associated somatic mutations in APC rather than to those in other components of the WNT signaling cascade, and to what extent this may be due to the loss of interaction between APC and actin-regulatory proteins and microtubules that affect cell migration, orientation, polarity, division and apoptosis, rather than the proliferation/differentiation generally associated with WNT/b-CATENIN signaling (for review see [16] ). However, at least in the mouse the C-terminal domains of Apc are dispensable for its tumor suppressing functions [17] . In addition, phenotypic changes observed after the conditional deletion of Apc including those on apoptosis, migration, differentiation and proliferation are rescued by concomitant deletion of the Wnt/b-catenin target gene Myc [18] .
Signaling threshold levels in vivo have been assessed by various approaches, including administration of (ant-) agonistic compounds, the (inducible) over-expression of transgenes and the creation of haploinsufficiency through the combination of knockout and hypomorphic alleles. Elegant combinations of different hypomorphic Apc alleles, for instance, have demonstrated that within the context of intestinal tumorigenesis, there is a clear correlation between gene dosage and phenotype severity [17, 19] . In particular, these studies implied an inverse correlation between the level of Apc protein expression and activation of the Wnt/bcatenin pathway, and in turn, proliferation and differentiation of epithelium along the crypt-villus axis as well as cell renewal in the stem cell compartment [20] . Here we genetically identify differences in signaling threshold levels that determine physiological and pathological outcomes during embryonic development and various aspects of tissue homeostasis in adult tissue. Using combinations of epistatically related hypomorphic alleles of components of the Wnt/b-catenin signaling cascade, we identify tissue-specific signaling threshold levels for anterior specification during embryogenesis, intestinal and hepatic homeostasis in the adult. Our observations add further support to the ''just-right'' model [21] of Wnt/b-catenin signaling activation where distinct dosages are required to perturb the self-renewal of stem cell populations and lead to neoplastic transformation in the intestine and liver.
Results/Discussion
Genetic modulation of full-length Apc expression in mouse embryonic fibroblasts
In order to modulate the activity of the Wnt/b-catenin pathway in the mouse, we took advantage of the Apc min [22] and Apc fl [23] alleles. The premature stop codon encoded by the Apc min allele encodes a truncated 850 amino acid Apc protein, which lacks the 15-and 20 aa repeats and Axin binding repeats required for bcatenin regulation [24] , while the unrecombined Apc fl allele results in attenuated expression levels of wild-type Apc mRNA [23] . We used Western blot analysis of lysates from mouse embryo fibroblasts (MEFs) to quantitate expression of full-length Apc protein and the capacity to augment Wnt3a-dependent signaling in cells from the corresponding Apc allele combinations. We observed an inverse relationship in the hierarchy of allele combinations between full-length Apc protein expression ( Figure 1A) , and signaling activity of the Wnt/b-catenin pathway recorded with a Tcf4 reporter plasmid ( Figure 1B ). Owing to the presence of residual amounts of full-length Apc protein, the two soluble Wnt antagonists Sfrp5 and Dkk1 were able to suppress Wnt3a-mediated reporter activation in cells of all tested allele combinations. However, in the presence of Wnt3a, pSUPERTopFlash reporter activity was inhibited less effectively by Sfrp5 and Dkk1 in cells with impaired expression of full-length Apc protein ( Figure 1B) . Therefore, genetic modulation of the expression levels of full-length Apc protein enables experimental manipulation of Wnt/b-catenin pathway activation for a given concentration of Wnt ligand or its soluble antagonists.
To assess whether the outcome of incremental modulation of Wnt/b-catenin signaling by genetic means in MEFs would impact differentially during development and in adult tissue homeostasis in vivo, we set out to generate adult mutant mice with genotypes comprising different combinations of Apc alleles. Surprisingly, we were unable to obtain Apc min/fl mice at term from crossing heterozygous Apc +/fl with Apc min/+ mice. Since homozygous Apc min , but not Apc fl , mice die in utero due to gastrulation defects [7] , we genotyped 117 embryos at E12 and found that all 30 Apc min/fl Author Summary Germline or somatic mutations in genes are the underlying cause of many human diseases, most notably cancer. Interestingly though, even in situations where every cell of every tissue of an organism carries the same mutation (as is the case for germline mutations), some tissues are more susceptible to the development of disease over time than others. For example, in familial adenomatous polyposis (FAP), affected persons carry different germline mutations in the APC gene and are prone to developing cancers of the colon and the rectum-and, less frequently, cancers in other tissues such as stomach, liver, and bones. Here we utilize a panel of mutant mice with truncating or hypomorphic mutations in the Apc gene, resulting in different levels of activation of the Wnt/b-catenin pathway. Our results reveal that different pathophysiological outcomes depend on different permissive signaling thresholds in embryonic, intestinal, and liver tissues. Importantly, we demonstrate that reducing Wnt pathway activation by 50% is enough to prevent the manifestation of embryonic abnormalities and disease in the adult mouse. This raises the possibility of developing therapeutic strategies that modulate the activation levels of this pathway rather than trying to ''repair'' the mutation in the gene itself.
embryos lacked all structures anterior to the hindbrain. Anterior morphological defects first became visible in E8.5-E9.5 Apc min/fl embryos, and remained restricted to that region throughout embryonic development (Figure 2A and 2B) . Histological crosssections of Apc min/fl E12 embryos revealed the presence of a prominent cap of neural tissue that formed at the most anterior part of the embryo, in the absence of cranial structures and the mandible ( Figure 2C ). Next we used the BAT::gal reporter allele to confirm excessive Tcf4-dependent b-galactosidase reporter activity in the neural tissue cap of Apc min/fl E15 embryos. As predicted from the Tcf-reporter analysis in MEFs, we also observed BAT::gal reporter activity around the fronto-nasal region with a gradual increase from Apc +/+ to Apc +/fl and Apc min/+ embryos. This was further extended to most abnormal anterior structures in the Apc min/fl embryos ( Figure 2E ). Furthermore, analysis of E5.5-E7.5 embryos by wholemount confocal immunohistochemistry revealed anterior extension of b-catenin expression in the anterior visceral endoderm, an axial signaling centre in the outer endoderm layer of early embryos [8, 25] , of Apc min/fl embryos when compared to their Apc +/fl counterparts ( Figure 2D ). However, ''headless'' Apc min/fl embryos were present at the expected Mendelian ratios until E15.5 (Table S1A ) and live embryos could still be detected at E17.5 (Theiler stage 25-26) (Figure 2A ) but at less than the expected Mendelian ratio. Our observations therefore support a role for limiting Apc-dependent signaling) functions during the development and patterning of the most anterior structures of the embryo similar to that proposed for excessive Wnt3 signaling in Dkk1-deficient or compound mutant Dkk1 +/2 ;Wnt3 +/2 mice [9, 20] , and reminiscent of the function played by Otx2 [26] .
To establish that the ''headless'' phenotype in Apc min/fl mice arose from altering the extent of Wnt/b-catenin signaling rather than arising from other potentially dominant-negative activities mediated by the truncated Apc min protein, we conducted three further genetic experiments. First, we created a more severely 580 amino acid truncated Apc protein by excising exon 14 in Apc +/fl mice that were crossed with the CMV:Cre deletor strain to induce a germline nonsense frame-shift mutation in the corresponding recombined Apc 580D allele. ;Ctnnb1 +/2 mice at weaning age at a similar ratio, while among E13.5 embryos, all four possible genotypes were represented at comparable frequencies (Table S1C and Figure S1 ). Importantly, Apc min/fl ;Ctnnb1 +/2 mice developed normally into fecund adults ( Figure 2B and data not shown), suggesting that limiting Wnt/b-catenin signaling corrected the development of detrimental phenotypes observed in Apc min/fl mice.
Since the atypical Wnt receptor component Ryk has recently been suggested to amplify Wnt signaling during cortical neurogenesis through b-catenin-dependent as well as independent pathways [27] , we also tested whether the ''headless'' phenotype was promoted by Ryk activity. However, and in contrast to bcatenin, the embryonic lethality of Apc min/fl mice was not rescued by genetically limiting the expression of the atypical tyrosine kinase Ryk, because we failed to recover either Apc min/fl ;Ryk +/2 or Apc min/fl ;Ryk -/-compound mutant mice at weaning (Table S1D ), suggesting that Ryk expression was not contributing to the Wnt/bcatenin induced phenotype.
Collectively, our observations extend previous reports that identified a Wnt signaling gradient along the anterior-posterior axis and a requirement for Dkk1 and other Wnt antagonists at the anterior end to prevent posteriorization [3] [4] [5] [6] 28, 29] . In particular, our experiments clarify genetically that the tight signaling requirements for head morphogenesis previously attributed to Apc or the extracellular components Dkk1 [3] , Sfrp [4, 30] , Wnt3a [9] and Wnt8a [5] occur exclusively through the Wnt/b-catenin pathway.
Unlike Apc min/fl embryos, Apc min/min embryos die around the time of gastrulation [7] , consistent with our observation that Apc MEFs (see below). Since the morphological defects in E4.75 Apc min/min embryos correlate with excessive nuclear b-catenin in the epiblast and primitive ectoderm [8] , we also examined the effect of genetically limiting b-catenin in these embryos. Unlike the phenotypic rescue observed in Apc min/fl ;Ctnnb1 +/2 mice, we detected Apc min/min ;Ctnnb1 +/2 embryos only at E4.5 and E5.5 but not at later stages (E6 and E7). This finding is reminiscent of the time points of embryonic death of Apc min/min embryos [7] and suggested that reduction of Wnt/b-catenin signaling was insufficient to rescue their death immediately after gastrulation (data not shown). Therefore, higher threshold levels of Wnt/b-catenin signaling selectively inhibit development at an earlier stage (i.e. gastrulation) and genetic reduction of Wnt/b-catenin signaling through ablation of one Ctnnb1 allele reduces signaling only below the threshold that is tolerated during later stages of development. However, we cannot formally exclude other essential function(s) of the full-length Apc protein, which could be provided by residual full-length protein encoded by the Apc fl allele, and which may be required around the time of gastrulation.
Threshold levels in intestinal polyposis
Apc min/+ mice develop intestinal polyposis upon spontaneous LOH of the wild-type Apc allele which arises from centromeric somatic recombination [31, 32] . Meanwhile, genetic studies estimated the polyposis threshold level to correspond to 10-15% of the full-length protein produced from biallelic Apc expression [19] . We therefore established aging cohorts of mice harbouring different Apc allele combinations to constitute an allelic series for Wnt/b-catenin signaling based on the results in Figure 1 . As observed previously, Apc fl/fl mice on a mixed 129Sv x C57BL/6 background remained free of intestinal polyps (.18 month, n = 24), while all Apc min/+ mice (n = 22) developed macroscopic lesions primarily within the proximal portion of the small intestine. Although tumor multiplicity and incidence was reduced in Apc min/fl ;Ctnnb1 +/2 mice, leaving 6 of 15 mice (40%) free of polyps ( Figure 3A) , the remaining macroscopic lesions were of tubulo-villous structure and of similar size to those observed in age-matched Apc min mice ( Figure 3B ). The similar latency of disease onset between Apc min/+ and Apc min/fl ;Ctnnb1 +/2 mice suggests a common requirement for LOH. We therefore amplified exon 14 from polyps which contain the min allele-specific A.T transition to confirm LOH in all polyps from Apc min (n = 12) and Apc min/fl ;Ctnnb1 +/2 mice (n = 4) ( Figure 3C and data not shown). Based on our in vitro analysis (Figure 1) , these results are similar to observations by Oshima et al. showing a requirement of less than 30% of wild-type Apc to prevent Wnt signaling from reaching the permissive threshold for intestinal polyps to form [33] . Surprisingly, restricting the pool of available cellular b-catenin in Apc min/fl ; Ctnnb1 +/2 mice selectively reduced tumor multiplicity rather than tumor size when compared to Apc min mice. This suggests that, once LOH has occurred, Wnt/b-catenin signaling exceeds the permissive threshold level, even in light of a 50% reduction in b-catenin and fuels maximal tumor growth, which indeed may be mediated most effectively by submaximal Wnt activity [34] .
Threshold levels of hepatocellular carcinogenesis
In humans, de-regulated WNT/b-catenin signaling plays an important role during onset and progression of hepatocellular carcinomas (HCC) and frequently arises from either dominant mutations in the CTNNB1 (b-catenin) gene, or biallelic inactivation of the AXIN1 and AXIN2 genes that involves LOH associated with somatic (epi-)mutation [35] [36] [37] . Somatic APC mutations, by contrast, are rarely associated with liver carcinogenesis, but FAP patients with germline APC mutations frequently develop hepatoblastomas as well as colonic adenocarcinomas [38] . In addition, adenovirally transduced, complete Apc gene inactivation in the murine liver resulted in hepatomegaly-associated mortality [39] , while its sporadic inactivation triggered the development of HCC [40] . We therefore assessed the incidence of liver tumors in moribund mice of the different Apc allele combinations. We found that all Apc fl/fl mice (n = 15), but none of their Apc fl/fl ;Ctnnb1
littermates (n = 8), had developed HCC by 450 days of age ( Figure 4A and 4B), but remained free of intestinal polyps ( Figure 3A ). We also used PCR analysis to exclude Creindependent, spontaneous recombination of the Apc fl allele(s) in these tumors ( Figure S2 ). Taken together with our observation of a reduced (but not complete loss) of Apc protein, this argues that tumors are formed with low level Apc and not in the absence of Apc. Therefore, our results suggest not only that HCC formation can occur due to excessive Wnt/b-catenin signaling but importantly that the permissive signaling threshold for hepatic tumorigenesis is lower than that for intestinal tumorigenesis consistently associated with LOH. Surprisingly, we observed HCC in 47% of Apc min/fl ; Ctnnb1 +/2 mice (n = 15) including 20% that showed intestinal comorbidity. Survival analysis of mice from this cohort, where disease was confined either to the intestine (n = 6) or the liver (n = 4; Figure 3D ), suggested the requirement for a stochastic secondary event to occur akin to intestinal Apc LOH. However, our genomic analysis of hepatic biopsies from Apc min/fl ;Ctnnb1 +/2 mice confirmed the absence of Apc LOH ( Figure 4A ), while qPCR and Western blot analysis revealed similar Apc expression between hepatic lesions and adjacent unaffected tissue from Apc fl/fl mice ( Figure 4C ). As expected, expression of Wnt target genes in unaffected livers from Apc fl/fl mice was elevated compared to livers from wt mice ( Figure 4D ). Meanwhile, in Apc fl/fl mice we found further, tumorspecific overexpression of some Wnt-target genes (incl. Cd44) that coincided with attenuation of others (notably encoding the negative regulators Axin2, Dkk2 and Wif1).
In order to clarify the nature of potential additional somatic mutations that may affect or cooperate with Wnt/b-catenin signaling, we excluded the presence of activating mutations in Ctnnb1-exon3 that would ablate the negative regulatory phosphorylation sites in b-catenin (Table S2A) . We also failed to identify aberrant hypermethylation of the proximal Axin2 promoter ( Figure 4E ) and also excluded activating mutations in codons 12, 13 or 61 of H-Ras (Table S2B) , although Harada et al. previously observed that simultaneous introduction of H-Ras and a constitutively active form of b-catenin by adenoviral gene transfer conferred HCC, while introduction of b-catenin alone did not [41, 42] . Indeed, exposure of Apc fl/fl mice to the liver-specific carcinogen diethylnitrosamine (DEN), which is known to promote mutations in H-Ras, resulted in a higher tumor incidence than in Apc +/fl mice ( Figure 4F) 6414 mm 3 (n = 9), p = 0.036; Mann-Whitney test; mean 6 SEM; n = 9) suggesting that the extent of aberrant Wnt/b-catenin activity may control both initiation and progression of lesions in the liver.
Collectively, these data suggest differential signaling threshold requirements for intestinal and hepatic tumorigenesis and likely differences in the molecular mechanisms by which Wnt/b-catenin signaling promotes tumorigenesis in these two tissues. The relatively low proliferative activity of the hepatic stem cell compartment, for instance, may provide protection from Apc LOH, even when facilitated by haploinsufficient expression of a recQ-like DNA helicase in Apc min/+ ;Blm Cin/+ compound mutant mice which remain free of HCC [43] . In light of the lack of Axin2 promoter hypermethylation, the reduction of tumor-specific Axin2 expression may arise from other stochastic events. For instance, the AXIN2 locus contributes to some cancers by LOH or rearrangements in humans [44] . On the other hand, chronic inflammation and the associated excessive activation of the Interleukin-6 pathway may cooperate with activating mutations in CTNNB1 during malignant transformation of human HCC [45] . Despite similar Tcf4 reporter activity recorded between Apc fl/fl and Apc min MEFs, Apc min mice remained free of HCC. This observation may be explained by the premature death of Apc min relative to Apc fl/fl mice ( Figure 3D ) together with the late onset of liver tumorigenesis. Indeed, we observe hepatic tumors in the Apc min/fl ; Ctnnb1 +/2 mice which live longer than Apc min mice. On the other hand, hepatic tissue shows exquisite sensitivity to differential threshold levels of Wnt/b-catenin signaling, whereby the resulting signaling gradient provides a mechanism for metabolic liver zonation [39] . Indeed, we observed here that partial attenuation of full-length Apc expression in Apc fl/fl mice not only increased the number of cells with Figure 5A and 5B), but also altered expression of Wnt target genes and liver zonation. In particular, and in agreement with our previous findings [46] , we observed that attenuation of fulllength Apc favored expansion of a perivenous gene expression program (incl. GS, Glt1 and RHBG) at the expense of a periportal signature (incl. CPS, Arg1 and Glut2) ( Figure 5A and 5C). Our observation that aberrant Wnt signaling in Apc fl/fl mice in the absence of additional somatic mutations in H-Ras bias towards tumors with perivenous characteristics is consistent with the finding that H-Ras mutated HCCs favor a periportal gene expression program [47] .
Reconciling tissue-specific phenotypes against different levels of Wnt/b-catenin signaling
To gain biochemical insights into the extent to which Wnt signaling thresholds are related to the tumorigenic response in mice, we generated MEFs of genotypes similar to those of cells having undergone Apc LOH in Apc min mice. In particular, we inactivated the latent Apc fl allele by Cre-mediated recombination in MEFs following infection with an AdCre-GFP adenovirus that expressed the Crerecombinase as a GFP-fusion protein ( Figure S3 ). Western blot analysis confirmed expression of the 580 amino acid truncated protein encoded by the recombined Apc 580D allele, in the presence of the 850 amino acid Apc min protein ( Figure 6A ). To prevent our analysis from being affected by potential ''plateau effects'', we stimulated MEFs with submaximal concentrations of Wnt3a and found a ,3-fold increase in Tcf-reporter activity between cells harboring the unrecombined Apc fl or recombined Apc 580D allele, respectively ( Figure 6B, ), and the comparison suggested similar Tcf4-reponsivenes between Apc min/+ and Apc fl/fl cells. As predicted from the extent of the activating Apc mutations, we also observed a gradual increase of Tcf reporter activity in the absence of Wnt3a ligand ( Figure S4 ).
Since systemic effects observed in adult Apc min/+ mice may arise secondary to LOH-dependent intestinal tumorigenesis, we next used Apc fl/fl mice to explore this in the context of the Wnt/b-catenin signaling requirement for the maintenance of the hematopoietic cell population [48] . Specifically, Apc min/+ mice develop lymphodepletion around the time when intestinal tumors are observed [49] , and this is associated with a progressive loss of immature and mature thymocytes, and the depletion of splenic natural killer (NK) cells. tion phenotype persisting in tumor-bearing irradiated Apc min/+ mice that have been reconstituted with wild-type bone marrow [49] and our observation that thymic atrophy and associated T-cell depletion reported by Coletta et al., [49] in their tumor bearing 14 week old Apc min/+ mice is not a reproducible finding at 17 weeks in our Apc min/+ colony (data not shown) which displays a relative delay in polyposis onset.
The present study underscores the power of hypomorphic alleles in the mouse to understand mechanisms that help to explain at the molecular level the specificity of pleiotropic signaling cascades. Here, we propose the existence of differential permissive Wnt/b-catenin signaling threshold levels during development and tissue homeostasis, and how they relate to each other with respect to specific pathophysiological outcomes. Combining biochemical assessment of different Apc allele combinations in MEFs with the corresponding mouse phenotype genetically defines threshold levels that are lower for liver tumorigenesis than for influencing cellular identity along the anterior-posterior axis, which in turn are lower than that required for intestinal tumorigenesis ( Figure 6B ). Our data complement those by Ishikawa et al [50] who observed a more severe head morphogenesis defect in mice homozygous for the hypomorphic Apc neoR allele which showed an 80% attenuation of full-length Apc protein (compared to ,70% in Apc min/fl cells, Figure 1A ) and a 7-fold increase in Tcf4-reporter activity (compared to ,5.5-fold in Apc min/fl cells, Figure 1B and Figure 6B ). Previously, we have shown that functional cooperation between individually insufficient (epi-) genetic alterations induced sufficient aberrant Wnt/b-catenin signaling to trigger intestinal tumorigenesis in compound A33 Dnmt3a ;Apc min mice, with polyps characterized by retention of the wild-type Apc allele and epigenetic silencing of the Sfrp5 gene [51] . Together with the findings presented here, these observations add further support to the ''just-right'' signaling model which predicts cellular transformation to require specific and distinct dosages of Wnt/b-catenin signaling in intestinal, mammary or hepatic cells, and which was based on the observation that LOH in mice carrying the hypomorphic Apc 1572T allele predisposed to metastatic mammary adenocarcinomas rather than intestinal or hepatic tumorigenesis [52] . Indeed, analysis of somatic mutations found in polyps of FAP patients indicates an active selection process favoring APC genotypes that provide residual levels of b-catenin regulation over its complete loss, which would trigger maximal activation of the Wnt/b-catenin pathway [21] . Furthermore, our results demonstrate a lower requirement of Wnt/b-catenin activation levels for neoplastic transformation of hepatocytes than of intestinal epithelium. Meanwhile, human HCC are frequently associated with somatic mutations in AXIN1 or AXIN2 rather than with those in APC [36, 37] suggesting that APC truncation mutations may be selected against during the process of hepatocyte transformation. Our findings that the frequency of HCC is higher in Apc fl/fl mice than in Apc min/fl ;Ctnnb1 +/2 mice (despite the higher Tcf reporter activity in MEFs of the latter genotype) may not only be accounted for by the shorter overall survival of Apc min/fl ;Ctnnb1 +/2 mice, but also predicted from the ''just-right'' signaling model [21, 52] .
Our data also implies that Wnt/b-catenin signaling is likely to conform to cell type-specific bistable switches, where the input stimulus must exceed a threshold to change from one cellular state (and associated response) to another. In the context of Apc LOHdependent intestinal polyposis, for instance, the predicted two-fold increase of Wnt/b-catenin signaling between Apc min/D ;Ctnnb1 Figure 3D ). Indeed, a recent report delineates a nested feedback-loop that may include a Wnt signaling-associated MAPK cascade [53] as one of the components which provides the non-linear input-output relationship for GSK3b and associated Wnt/b-catenin activity [54] to generate the dramatic threshold responses that characterize a bistable system. Differential sensitivity to genetic dosage provides the basis for establishing therapeutic windows when targeting non-mutated components in diseased tissue. Indeed, for instance, the notion of therapeutic exploitation of non-oncogene addiction is based on the difference in signaling thresholds tolerated between normal and neoplastic cells. Based on our hitherto limited capacity to target and/or compartmentalize drug delivery, global single-allele inactivation models may provide a convenient first screen to identify potential drug targets. Here, we extend this concept from our previous findings for Stat3 in the context of inflammationassociated gastric cancer [55] to Ctnnb1 in tumors of the liver and intestine and associated aberrant Wnt signaling.
Materials and Methods

Ethics statement
All animals were handled in strict accordance with good animal practice as defined by the relevant national and/or local animal welfare bodies, and all animal work was approved by the appropriate committee.
Mice
Heterozygous Ctnnb1
+/2 mice were generated by excising exons 3-6 from the germline following the mating Ctnnb1 fl/fl males with female C57Bl/6 E2a:Cre mice [56] . Ryk +/2 , the Apc mutant Apc min/+ and Apc fl/fl mice and the BAT-gal transgenic reporter mice have been described previously [22, 23, 57, 58] . All experimental mice were on a mixed genetic 129Sv x C57BL/6 background.
Quantitative PCR (qPCR) expression analysis qPCR analysis from liver was performed as described [59] . Following extraction of total RNA with TRIzol reagent (Sigma), first strand complementary DNA was synthesized using the Omniscript RT kit (Qiagen). The PCR reactions were carried out under the following conditions: 94uC for 2 min, denaturation at 92uC for 30 s, annealing at 56uC for 30 s and extension at 72uC for 45 s. Primers were obtained from Invitrogen. The number of cycles was 20 for GAPDH, 25 for Arginase1, Glut2 and RHGB, and 30 for b-catenin and Apc. The calculation of relative expression ratios was carried out with the Relative Expression Software Tool (REST) Multiple Condition Solver (MCS) (http://www.gene-quantification.com/) using the pairwise fixed reallocation randomization test. Primers used are listed in Table S3 . Tissue fixation, embedding, and processing Dissected liver tissue was fixed for 1 h in 4% paraformaldehyde or overnight in 10% formalin (Sigma) at 4uC depending on the antibody used (see below). After fixation, tissue samples were transferred to 70% ethanol and embedded in paraffin wax.
Immunohistochemical analysis of adult
Samples were prepared as described previously [46] . Immunoperoxidase staining for GS, CPS I and CYP2E1 (4% PFA) and bcatenin (formalin) was carried out as follows. Sections were dewaxed in Histoclear for 7 min. Sections were washed in PBS and blocked for 30 min in 2% Roche blocking buffer (Roche) before addition of the following antibodies: anti-mouse GS (1:400; BD Transduction Laboratories), anti rabbit CPS (1:1,000; a kind gift of Wouter Lamers), and CYP2E1 (1:500; a kind gift of Magnus Ingelman-Sundberg) in blocking buffer overnight at 4uC. Immunostaining for b-catenin (1:50; BD Transduction Laboratories) was carried out as previously described [60] . Excess primary antibody was removed by washing 3 times in PBS for 10 min each. Sections were incubated with the DAKO Envision peroxidase-labeled antimouse or rabbit secondary antibody polymer for 30 min. The DAB substrate-chromogen mixture was added to the sections and allowed to develop for 10 min. The reaction was terminated in dH2O and the sections counterstained with hematoxylin where appropriate. Specimens were observed using a Leica DMRB microscope. Image collection from the Leica was made with a Spot camera and images collated into figures in Photoshop.
Cell culture and transfections
Mouse embryo fibroblasts (MEFs) were derived from E13 embryos and propagated in DMEM supplemented with 10% FBS. The day before transfection, cells were seeded at 5610 4 cells/well into 24-well plates. Wnt3a-conditioned medium was a gift from Liz Vincan (Peter MacCallum Cancer Institute, Melbourne) and Nicole Church (JPSL, Ludwig Institute for Cancer Research, Melbourne) and the recombinant human Dkk1-was from R&D Systems (#1090-Dk). Transfections were carried out using either FuGENE 6 transfection reagent (Roche) or nucleofector (Amaxa), 200 ng pSuperTOPflash, 4 ng pRL-CMV and 200 ng of pCMV-HA-SFRP5 expression construct. Two days later, cultures were processed using the Dual-Luciferase Reporter Assay kit (Promega) and luminescence was measured using a Lumistar Galaxy luminometer (Dynatech Laboratories).
Induction of liver carcinogenesis
Mice were injected intraperitoneally with a single dose of diethylnitrosamine (DEN) (10 mg/ml) at 40 mg/kg at 14 days of age. Mice were sacrificed 6-8 months later and livers were scored for the presence of macroscopic tumors.
Flow cytometry
Single cell suspensions from spleens were prepared by passing organs through a 40 mm mesh. Cell suspensions were treated with NH 4 Cl to lyse red blood cells, and then nonspecific binding was blocked by incubating with mouse Fc block (2.4G2). The cells were incubated for 30 min at RT with the relevant fluorochromeconjugated antibodies to CD3 (clone 2C11), CD4 (GK1.5), CD8 (53-6.7) and DX5 (#558295). All antibodies and Fc Block for flow cytometry were purchased from BD Biosciences, San Jose, CA. Expression of surface markers on cells was detected using a FACSCalibur flow cytometer (BD Biosciences) and analyzed using the FlowJo software (Tree Star, Inc.) Forward scatter/side scatter (FCS/SSC) gating was used to exclude debris and doublets and dead cells were gated out on the basis of PI positivity measured on the FL-3 channel.
LacZ staining for embryos
Embryos are killed by submerging in ice-cold PBS for a few minutes and fixed by rocking for 45 min in ice-cold 4% PFA in PBS. Specimens are washed 365 min in PBS and subsequently incubated o/n at 30uC in X-gal staining solution. After washing in PBS for a few minutes, stained embryos were photographed.
Western blotting
Cells were lysed using Triton-X based lysis buffer (30 mM Hepes), 150 mM NaCl, 1% Triton-X-100, 2 mM MgCl 2 ), with Complete EDTA-free protease and phosphatase inhibitor cocktail (Roche). This was followed by centrifugation at 13000 g for 5 min at 4uC and denaturing at 95uC for 5 min. Protein concentration was determined using a BIO-RAD assay kit. Proteins were then separated by SDS-PAGE (Invitrogen), blotted onto nitrocellulose and incubated with the appropriate antibody overnight. After incubation with the secondary antibody, proteins were visualized using ECL chemiluminescence detection kit (GE Healthcare). For detection of APC, cell lysates were prepared by resuspending cells in ice-cold Lysis buffer [20 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% TritonX-100, 1% deoxycholate and Complete EDTA-free protease inhibitor cocktail] and incubation on ice for 15 min. Lysates were clarified by microcentrifugation at 16,060 g for 30 min at 4uC. Total cell lysates were then analysed by SDS-PAGE (3-8% NuPAGE) and detected using the Odyssey infrared imaging system (Odyssey). Quantification of Western blots was performed by using Image J pixel analysis (NIH Image software). Data from Western blots is presented as band density normalized to the loading control, and is representative of three independent experiments. Anti-Active-b-Catenin (anti-ABC), clone 8E7, was from Upstate (#05-665), rabbit polyclonal antibody to the Nterminus of APC (H-290) was obtained from Santa Cruz Biotechnology (Santa Cruz) and anti-mouse Actin (AC-40) was from Sigma-Aldrich.
Apc LOH determination, promoter methylation analysis
Parts of exon 16 containing the Min allele specific T.A substitution was PCR-amplified and the gel-purified amplicons were sequenced on an ABIprism377 DNA sequencer (Applied Biosystems). Apc (ex16) forward primer 59-TCACCGGAGTAAG-CAGAGACAC-39, reverse primer 59-TTTGGCATAAGGCATA-GAGCAT-39. Bisulfite treatment of genomic DNA and methylation specific PCR was carried out as described [61] .
Production of adenoviruses and adenoviral infection
Adenovirus expressing Cre Recombinase fused to enhanced green fluorescent protein (GFP; Cre-GFP) was produced by cloning a cDNA encoding Cre-GFP into pShuttle, the adenoviral transfer vector (Q-BIOgene). Linearised plasmid was then co-transformed into Escherichia coli with pAdEasy1 (Ad5DE1/DE3) (Q-BIOgene). The pAdCreGFP was linearised and transfected into Q-HEK293A cells (Q-BIOgene) using the calcium phosphate method (Promega). 10 days after transfection, adenoviral infected cells were collected and the adenovirus was released by three rounds of freeze/thawing, and amplification in Q-HEK293A cells, as described in the protocol (Q-BIOgene). For Tcf4 reporter assays MEFs were plated at 5610 4 cells/well and were transfected with pSuperTOPflash, and pRenillaluc. After 24 h, cells were infected with either Ad-LacZ (control virus) or Ad-CreGFP (20 ml/well, TCID50 1.995610 8 /ml). 48 h after infection, cells were lysed and assayed for luciferase activity.
For Western blot analysis, MEFs were plated at 1.5610 5 cells/well in 6 well plates and infected with AdCreGFP (20 and 50 ml/well, TCID50 1.995610 8 /ml) or Ad-LacZ for 48 h. For microscopy, MEFs were plated on glass coverslips, infected with virus, and after 48 h, infected cells were washed twice with PBS and fixed in 4% formaldehyde/PBS for 5 min. DIC and fluorescent images were produced using a Nikon 90i microscope.
Statistical analysis
Statistical significance was determined by unpaired t-test or, where indicated, using Mann-Whitney analysis.
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